Search
Browse By Day
Browse By Time
Browse By Panel
Browse By Session Type
Browse By Topic Area
Browse Posters
Search Tips
Register for SRCD23
Personal Schedule
Welcome Letter
Program Guide
Change Preferences / Time Zone
Sign In
Introduction. Evidence on the impact of the COVID-19 pandemic on children and caregiver’s mental health has primarily focused on depression, anxiety, and general stress (Loades et al., 2020; Prati & Mancini, 2021). Few have examined traumatic reactions, despite evidence that isolation/quarantine is associated with an increased risk of post-traumatic stress symptoms (Brooks et al., 2020; Rider et al., 2021). To address this, we developed the Pandemic-related Traumatic Stress Scale (PTSS; Margolis et al., 2021) to assess five domains of stress reaction symptoms based on the DSM-5 Acute Stress Disorder criteria: intrusion, dissociation, avoidance, arousal regulation problems, and negative mood (American Psychiatric Association, 2022). The scale is designed for self-report by adults and adolescents (13-21 years) and caregiver report on symptoms observed in 3-12-year-olds.
Hypotheses. We hypothesized the PTSS was unidimensional, had comparable structure across diverse populations, and was positively associated with general stress, anxiety, and depressive symptoms, and negatively associated with life satisfaction. Further, we hypothesized group differences: (1) postpartum individuals would have higher PTSS scores compared to pregnant individuals (Molgora & Accordini, 2020); (2) adult caregivers of younger children (<5 years) would have higher PTSS scores compared to those of older children (5-12 years) and adolescents (13-21 years; Brooks et al., 2020); (3) female adult caregivers would have higher PTSS scores compared to male adult caregivers (Wang et al., 2020); and (4) older and female children/adolescents would have higher PTSS scores compared to younger and male children/adolescents (Loades et al., 2020; Marques de Miranda et al., 2020).
Study Population and Methods. Data came from four samples drawn from the ECHO Program: pregnant/postpartum individuals (n = 1,656), adult caregivers (n = 11,483), adolescents (n = 1,795), and caregivers reporting on 3-12-year-olds (N = 2,896), all of whom completed the PTSS between April 2020 and August 2021. We used Mokken scale analysis to examine unidimensionality and reliability, Pearson correlations to evaluate construct validity, and ANOVAs to identify age and sex differences.
Results. Mokken analysis resulted in a unidimensional scale that retained nine of the original 10 items (alpha >.8; Table 1). We detected small to moderate positive associations with depression (r = .23 - .47), anxiety (r = .2 - .62), and general stress (r = .46 - .58), and negative associations with life satisfaction (r = -.35- -.37) across the four samples. Adult caregivers had the highest PTSS scores (M = 18.57, SD = 6.46), followed by adolescents (M = 18.32, SD = 7.16), pregnant/postpartum individuals (M = 17.4, SD = 6.38), and children (M = 14.15, SD = 5.62; Figure 1). Caregivers of younger children, females, and older youth had higher PTSS scores compared to caregivers of older children, males, and younger youth.
Results suggest the PTSS is a reliable measure to quantify pandemic-related traumatic stress. The scale will enable researchers and clinicians to differentiate general stress, depression, and anxiety from pandemic-related traumatic stress symptoms and potentially identify individuals with higher levels of traumatic stress symptoms who may require targeted interventions.
The ECHO Consortium
Courtney King Blackwell, Northwestern University
Presenting Author
Phillip Sherlock, Northwestern University
Kathryn L. Jackson, Northwestern University
Julie A. Hofheimer, University of North Carolina School of Medicine
Molly A. Algermissen, Columbia University Irving Medical Center
Akram Alshawabkeh
Lyndsay A. Avalos, Kaiser Permanente North California, Division of Research
Tracy Bastain, Keck School of Medicine of the University of Southern California
Clancy Blair, New York University
Michelle Bosquet Enlow, Boston Children's Hospital
Patricia Brennan, Emory University
Carrie Breton, Keck School of Medicine of the University of Southern California
Nicole R Bush, University of California - San Francisco
David Cella, Northwestern University
Aruna Chandran, Johns Hopkins University Bloomberg School of Public Health
Shaina Collazo, Icahn School of Medicine at Mount Sinai
Liz Conradt, Duke University
Sheila E Crowell, University of Utah
Sean C Deoni, Brown University
Jean A. Frazier, University of Massachusetts Chan Medical School
Jody M. Ganiban, George Washington University
Amy Elliott, Avera Health
Diane R. Gold, Harvard Medical School, Harvard University, Brigham and Women's Hospital
Julie Herbstman, Columbia University
Christine Joseph, Henry Ford Health System
Margaret R. Karagas, Dartmouth College Geisel School of Medicine,
Barry M Lester, Brown University-Women & Infants Hospital of Rhode Island
Jessica A. Lasky-Su, Harvard University, Brigham and Women’s Hospital
Leslie D. Leve, University of Oregon
Kaja Z. LeWinn, University of California - San Francisco
Elisabeth McGowan
Kimberly S. McKee, University of Michigan Medical School
Rachel L. Miller, Icahn School of Medicine at Mount Sinai
Jenae M Neiderhiser, Pennsylvania State University, University Park
Thomas G O'Connor, University of Rochester Medical Center
Emily Oken, Harvard Medical School, Harvard University, Brigham and Women’s Hospital, Harvard Pilgrim Health
T. Michael O'Shea, University of North Carolina School of Medicine
David Pagliaccio, New York State Psychiatric Institute
Rebecca Schmidt, University of California, Davis
Anne Marie Singh, University of Wisconsin School of Medicine and Public Health
Joseph B. Stanford, University of Utah School of Medicine
Leonardo Trasande
Rosalind Wright
Cristiane Duarte, New York State Psychiatric Institute
Amy Margolis, Columbia University